Live Breaking News & Updates on Agios Pharmaceuticals Trading Down

Stay updated with breaking news from Agios pharmaceuticals trading down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FY2024 EPS Estimates for Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Lifted by Analyst

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Analysts at Zacks Research raised their FY2024 EPS estimates for Agios Pharmaceuticals in a note issued to investors on Thursday, January 25th. Zacks Research analyst A. Chakraborty now anticipates that the biopharmaceutical company will post earnings of ($6.05) per share for the year, up from their previous […] ....

Hong Kong , Brian Goff , Jacqualyna Fouse , Lazard Asset Management , Agios Pharmaceuticals Trading Down , Agios Pharmaceuticals Company Profile , Agios Pharmaceuticals Inc , Tower Research Capital , Analysts At Zacks Research , Zacks Research , News Ratings For Agios Pharmaceuticals Daily , Hong Kong Ltd , Ameritas Investment Partners Inc , Goldman Sachs Group , Agios Pharmaceuticals , Institutional Investors Weigh In On Agios Pharmaceuticals , China Universal Asset Management Co , Free Report , Agios Pharmaceutical , Pharmaceuticals Trading Down , Get Free Report , Universal Asset Management , Kong Ltd , Research Capital , Asset Management , Ameritas Investment Partners ,

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Insider Sells $74,088.02 in Stock

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) insider Theodore James Jr. Washburn sold 2,918 shares of the company’s stock in a transaction on Monday, August 7th. The shares were sold at an average price of $25.39, for a total value of $74,088.02. Following the completion of the sale, the insider now owns 2,741 shares […] ....

New Zealand General , New Zealand , Theodore James Jr , Vanguard Group Inc , Agios Pharmaceuticals Trading Down , Agios Pharmaceuticals Company Profile , Wellington Management Group , Agios Pharmaceuticals Inc , Jpmorgan Chase Co , Armistice Capital , Blackrock Inc , Hedge Funds Weigh In On Agios Pharmaceuticals , News Ratings For Agios Pharmaceuticals Daily , Agios Pharmaceuticals , Quarter For Agios Pharmaceuticals , Get Free Report , Theodore James , Pharmaceuticals Trading Down , Management Group , State Street Corp , Street Corp , Agios Pharmaceuticals Daily , Nasdaq Agio , Insider Trading , Nsider Trades ,

Agios Pharmaceuticals (NASDAQ:AGIO) Releases Earnings Results, Beats Estimates By $0.09 EPS

Agios Pharmaceuticals (NASDAQ:AGIO) Releases Earnings Results, Beats Estimates By $0.09 EPS
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , Jacqualyna Fouse , James William Burns , Agios Pharmaceuticals Inc , Agios Pharmaceuticals , Hong Kong Ltd , News Ratings For Agios Pharmaceuticals Daily , Sei Investments Co , Lazard Asset Management , Agios Pharmaceuticals Company Profile , Agios Pharmaceuticals Trading Down , Institutional Trading Of Agios Pharmaceuticals , Securities Exchange Commission , Earnings History For Agios Pharmaceuticals , Tower Research Capital , Envestnet Asset Management Inc , Get Free Report , Pharmaceuticals Trading Down , Director Jacqualyn , Exchange Commission , Kong Ltd , Research Capital , Asset Management , Sei Investments , Agios Pharmaceuticals Daily ,

Agios Pharmaceuticals (NASDAQ:AGIO) Posts Quarterly Earnings Results, Beats Expectations By $0.09 EPS

Agios Pharmaceuticals (NASDAQ:AGIO – Get Free Report) posted its quarterly earnings results on Thursday. The biopharmaceutical company reported ($1.51) EPS for the quarter, beating the consensus estimate of ($1.60) by $0.09, Briefing.com reports. Agios Pharmaceuticals had a negative return on equity of 19.77% and a negative net margin of 1,042.56%. The firm had revenue of […] ....

Theodore James Jr , James William Burns , Dimensional Fund Advisors , Agios Pharmaceuticals Inc , Insider Transactions At Agios Pharmaceuticals , Agios Pharmaceuticals Trading Down , Earnings History For Agios Pharmaceuticals , First Trust Advisors , News Ratings For Agios Pharmaceuticals Daily , Blackrock Inc , Vanguard Group Inc , Agios Pharmaceuticals Company Profile , Agios Pharmaceuticals , Get Free Report , Pharmaceuticals Trading Down , Theodore James , Street Corp , Fund Advisors , Trust Advisors , Agios Pharmaceuticals Daily , Nasdaq Agio ,

Agios Pharmaceuticals (NASDAQ:AGIO) Releases Quarterly Earnings Results, Beats Expectations By $0.09 EPS

Agios Pharmaceuticals (NASDAQ:AGIO – Get Free Report) announced its quarterly earnings results on Thursday. The biopharmaceutical company reported ($1.51) EPS for the quarter, topping the consensus estimate of ($1.60) by $0.09, Briefing.com reports. Agios Pharmaceuticals had a negative return on equity of 19.77% and a negative net margin of 1,042.56%. The business had revenue of […] ....

Brian Goff , Jacqualyna Fouse , Earnings History For Agios Pharmaceuticals , Fund Management Co , Agios Pharmaceuticals Inc , Institutional Trading Of Agios Pharmaceuticals , Agios Pharmaceuticals Company Profile , Sei Investments Co , Agios Pharmaceuticals Trading Down , Envestnet Asset Management Inc , Agios Pharmaceuticals , News Ratings For Agios Pharmaceuticals Daily , Principal Financial Group Inc , Securities Exchange Commission , Franklin Resources Inc , Get Free Report , Pharmaceuticals Trading Down , Director Jacqualyn , Exchange Commission , Asset Management , Financial Group , Fund Management , Sei Investments , Agios Pharmaceuticals Daily , Nasdaq Agio ,